4.7 Article

Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death

Journal

CELL DEATH AND DIFFERENTIATION
Volume 22, Issue 7, Pages 1219-1230

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2014.225

Keywords

-

Funding

  1. German Federal Ministry of Education and Research (BMBF) [01GN0951]
  2. German Heart Foundation/German Foundation of Heart Research [F/19/13]
  3. Deutsche Forschungsgemeinschaft (DFG) Klinische Forschergruppe KFO 274 'Platelets-Basic Mechanisms and Translational Implications'

Ask authors/readers for more resources

Tissue damage due to apoptotic or necrotic cell death typically initiates distinct cellular responses, leading either directly to tissue repair and regeneration or to immunological processes first, to clear the site, for example, of potentially damage-inducing agents. Mesenchymal stem cells (MSC) as well as immature dendritic cells (iDC) and monocytes migrate to injured tissues. MSC have regenerative capacity, whereas monocytes and iDC have a critical role in inflammation and induction of immune responses, including autoimmunity after tissue damage. Here, we investigated the influence of apoptotic and necrotic cell death on recruitment of MSC, monocytes and iDC, and identified hepatocyte growth factor (HGF) and the alarmin high mobility group box 1 (HMGB1) as key factors differentially regulating these migratory responses. MSC, but not monocytes or iDC, were attracted by apoptotic cardiomyocytic and neuronal cells, whereas necrosis induced migration of monocytes and iDC, but not of MSC. Only apoptotic cell death resulted in HGF production and HGF-mediated migration of MSC towards the apoptotic targets. In contrast, HMGB1 was predominantly released by the necrotic cells and mediated recruitment of monocytes and iDC via the receptor of advanced glycation end products. Moreover, necrotic cardiomyocytic and neuronal cells caused an HMGB1/toll-like receptor-4-dependent inhibition of MSC migration towards apoptosis or HGF, while recruitment of monocytes and iDC by necrosis or HMGB1 was not affected by apoptotic cells or HGF. Thus, the type of cell death differentially regulates recruitment of either MSC or monocytes and iDC through HGF and HMGB1, respectively, with a dominant, HMGB1-mediated role of necrosis in determining tropism after tissue injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biophysics

Results of a multicenter phase I/II trial of TCR alpha beta and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients

Wolfgang A. Bethge, Matthias Eyrich, Stephan Mielke, Roland Meisel, Dietger Niederwieser, Paul G. Schlegel, Ansgar Schulz, Johann Greil, Donald Bunjes, Arne Brecht, Jurgen Kuball, Michael Schumm, Vladan Vucinic, Markus Wiesneth, Halvard Bonig, Kasper Westinga, Stefanie Biedermann, Silke Holtkamp, Sandra Karitzky, Michaela Malchow, Christiane Siewert, Rupert Handgretinger, Peter Lang

Summary: Haploidentical stem cell transplantation using TCR alpha beta/CD19-depleted grafts has shown promising results in high-risk patients, with low incidences of acute GVHD and relatively high overall and disease-free survival rates at 2 years post-transplantation.

BONE MARROW TRANSPLANTATION (2022)

Article Virology

Humoral response to SARS-CoV-2 and seasonal coronaviruses in COVID-19 patients

Ortwin Adams, Marcel Andree, Denise Rabl, Philipp N. Ostermann, Heiner Schaal, Erik Lehnert, Stefanie Ackerstaff, Lisa Mueller, Johannes C. Fischer

Summary: The study found that COVID-19 patients had relatively higher antibody levels against four seasonal human coronaviruses, with only slight elevation in levels for HCoV-HKU1 and HCoV-229E; Antibody levels against SARS-CoV-2 were significantly correlated with disease severity, while no association was found for antibodies against seasonal human coronaviruses.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Immunology

CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity

Maryam Hejazi, Congcong Zhang, Sabrina B. Bennstein, Vera Balz, Sarah B. Reusing, Melissa Quadflieg, Keven Hoerster, Stefan Heinrichs, Helmut Hanenberg, Sebastian Oberbeck, Marcus Nitsche, Sophie Cramer, Rita Pfeifer, Pranav Oberoi, Heiko Ruehl, Johannes Oldenburg, Peter Brossart, Peter A. Horn, Florian Babor, Winfried S. Wels, Johannes C. Fischer, Nina Moeker, Markus Uhrberg

Summary: This study reveals a novel functional divergence between NK cell subsets upon in vitro stimulation, marked by CD33 expression. By choosing suitable stimulation protocols, it is possible to preferentially generate CD33(+) NK cells combining efficient target cell killing and cytokine production, or alternatively CD33(-) NK cells, which produce less cytokines but are more efficient in antibody-dependent applications.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Identification of new RAD51D-regulating microRNAs that also emerge as potent inhibitors of the Fanconi anemia/homologous recombination pathways

Nina Hater, Katharina M. Iwaniuk, Carina Leifeld, Pia Grueten, Constanze Wiek, Katharina Raba, Fan Zhang, Johannes C. Fischer, Paul R. Andreassen, Helmut Hanenberg, Hans-Ingo Trompeter

Summary: This study investigates the expression profiles of microRNAs in different DNA repair-deficient cells and validates the regulatory effects of miR-141-3p, miR-369-3p, miR-15a-5p, miR-494-3p, and miR-544a on RAD51B and RAD51D. Further analysis reveals the widespread regulatory influence of these microRNAs on other FA/HR factors, and miR-494-3p directly reduces RAD51 foci formation while the mixture of miR-15a-5p, miR-494-3p, and miR-544a reduces HR activity.

HUMAN MOLECULAR GENETICS (2022)

Editorial Material Hematology

Production of COVID-19 Antibody Concentrates Using Immunoadsorption

Jannik Rothenburg, Silke Rink-Baron, Lisa Mueller, Philipp Niklas Ostermann, Johannes Fischer, Johannes Stegbauer, Anja Moldenhauer

Summary: Due to the unexpected outcomes in using convalescent plasma and its varying and often low concentrations of COVID-19 antibodies, German guidelines do not recommend its use. Instead, a strategy involving the selective collection and concentration of human immunoglobulins using immunoadsorption has been adopted.

TRANSFUSIONSMEDIZIN (2022)

Article Multidisciplinary Sciences

Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort

Noemi F. Freise, Smaranda Gliga, Johannes Fischer, Nadine Lubke, Matthias Lutterbeck, Miriam Scholer, Edwin Bolke, Hans Martin Orth, Torsten Feldt, Christoph Roemmele, Dominik Wilke, Jochen Schneider, Kai Wille, Christian Hohmann, Richard Strauss, Martin Hower, Andreas Ruf, Joerg Schubert, Nora Isberner, Melanie Stecher, Lisa Pilgram, Jorg J. Vehreschild, Frank Hanses, Tom Luedde, Bjorn Jensen

Summary: Establishing the optimal treatment for COVID-19 patients, especially immunocompromised and pre-diseased patients, remains challenging. Reliable data on the therapeutic use of convalescent plasma (CP) for high-risk patients are lacking. This study found that early administration of CP can reduce mortality in COVID-19 patients.

SCIENTIFIC REPORTS (2022)

Article Biology

Immunogenetic Predisposition to SARS-CoV-2 Infection

Claudia Lehmann, Henry Loeffler-Wirth, Vera Balz, Juergen Enczmann, Ramona Landgraf, Nicole Lakowa, Thomas Gruenewald, Johannes C. C. Fischer, Ilias Doxiadis

Summary: Since the beginning of the SARS-CoV-2 pandemic, immunogenetics has been found to play a crucial role in the susceptibility and severity of infection. This study investigated the association between various HLA alleles, blood group systems, and the molecular detection of COVID-19. The results showed that certain HLA alleles and blood group antigens were enriched in either the positive or negative group, suggesting their potential influence on COVID-19 infection.

BIOLOGY-BASEL (2023)

Article Oncology

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial

Tim Flaadt, Ruth L. Ladenstein, Martin Ebinger, Holger N. Lode, Helga Bjoerk Arnardottir, Ulrike Poetschger, Wolfgang Schwinger, Roland Meisel, Friedhelm R. Schuster, Michaela Doering, Peter F. Ambros, Manon Queudeville, Joerg Fuchs, Steven W. Warmann, Juergen Schaefer, Christian Seitz, Patrick Schlegel, Ines B. Brecht, Ursula Holzer, Tobias Feuchtinger, Thorsten Simon, Johannes H. Schulte, Angelika Eggert, Heiko-Manuel Teltschik, Toni Illhardt, Rupert Handgretinger, Peter Lang

Summary: This study investigates the use of haploidentical stem cell transplantation and the anti-GD2 antibody dinutuximab beta (DB) in treating patients with relapsed high-risk neuroblastoma (rHR-NB). The results show that DB therapy is feasible and improves the chances of cure in rHR-NB patients.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medical Laboratory Technology

Gender-Associated Variation in DOAC Levels

Anja Moldenhauer, Peter Hellstern, Till Hoffmann, Johannes C. Fischer

Summary: This study found significant differences in peak blood concentrations of rivaroxaban based on age and gender. Women and patients over 60 years old had higher peak concentrations. The findings suggest that gender and age should be taken into account when determining reference values for blood concentrations.

CLINICAL LABORATORY (2023)

Article Biochemistry & Molecular Biology

Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis

Nikolas H. Stoecklein, Georg Fluegen, Rosa Guglielmi, Rui P. L. Neves, Thilo Hackert, Emrullah Birgin, Stefan A. Cieslik, Monica Sudarsanam, Christiane Driemel, Guus van Dalum, Andre Franken, Dieter Niederacher, Hans Neubauer, Tanja Fehm, Jutta M. Rox, Petra Boehme, Lena Haeberle, Wolfgang Goering, Irene Esposito, Stefan A. Topp, Frank A. W. Coumans, Juergen Weitz, Wolfram T. Knoefel, Johannes C. Fischer, Ulrich Bork, Nuh N. Rahbari

Summary: By employing diagnostic leukapheresis (DLA) to screen large blood volumes, the sensitivity and quantity of circulating tumor cells (CTCs) in pancreatic adenocarcinoma (PDAC) can be improved, while providing ample material for genomic analysis. DLA-derived CS-CTCs can serve as a useful tool for identifying high-risk PDAC patients and optimizing treatment strategies.

MOLECULAR CANCER (2023)

Article Hematology

High-Throughput Next-Generation Sequencing of the Kidd Blood Group: Unexpected Antigen Expression Properties of Four Alleles and Detection of Novel Variants

Stephanie M. Vorholt, Veronika Lenz, Burkhard Just, Juergen Enczmann, Johannes C. Fischer, Peter A. Horn, Thomas A. Zeiler, Vera Balz

Summary: This study reports the molecular findings of the JK blood group, including allele frequencies and antigen prevalence data. The results demonstrate that genotyping tests can effectively identify compatible blood products for different populations, reducing the risk of transfusion reactions.

TRANSFUSION MEDICINE AND HEMOTHERAPY (2023)

Article Medicine, Research & Experimental

Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection

Johannes C. Fischer, Vera Balz, Danny Jazmati, Edwin Boelke, Noemi F. Freise, Verena Keitel, Torsten Feldt, Bjoern-Erik Ole Jensen, Johannes Bode, Tom Luedde, Dieter Haeussinger, Ortwin Adams, E. Marion Schneider, Juergen Enczmann, Jutta M. Rox, Derik Hermsen, Karin Schulze-Bosse, Detlef Kindgen-Milles, Wolfram Trudo Knoefel, Martijn van Griensven, Jan Haussmann, Balint Tamaskovics, Christian Plettenberg, Kathrin Scheckenbach, Stefanie Corradini, Alessia Pedoto, Kitti Maas, Livia Schmidt, Olaf Grebe, Irene Esposito, Anja Ehrhardt, Matthias Peiper, Bettina Alexandra Buhren, Christian Calles, Andreas Stoehr, Peter Arne Gerber, Artur Lichtenberg, Hubert Schelzig, Yechan Flaig, Amir Rezazadeh, Wilfried Budach, Christiane Matuschek

Summary: HLA haplotypes are associated with the severity and duration of COVID-19, and these associations are also influenced by sex and CCRR5 mutation.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)

Article Hematology

HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh

Shanmuganathan Chandrakasan, Sharat Chandra, Chengyu Prince, Lisa J. Kobrynski, Laura Lucas, Kiran Patel, Jolan Walter, Rebecca H. Buckley, Roland Meisel, Sujal Ghosh, Suhag H. Parikh

Summary: This study investigated the immune status of CD40 ligand (CD40L)-deficient carriers and the outcomes of hematopoietic stem cell transplantation (HSCT) using them as donors for CD40L-deficient patients. The results showed that the immune profiles of carriers were comparable to healthy controls, and HSCT using carriers as donors resulted in excellent immune reconstitution without immune dysregulation. The study also demonstrated higher CD40L expression in the T-follicular helper (Tfh) compartment of carriers, suggesting a potential advantage for CD40L-expressing Tfh cells.

BLOOD ADVANCES (2022)

Article Medicine, Research & Experimental

Acute cardiac side effects after COVID-19 mRNA vaccination: a case series

Noemi F. Freise, Milena Kivel, Olaf Grebe, Christian Meyer, Bahram Wafaisade, Matthias Peiper, Tobias Zeus, Jan Schmidt, Judith Neuwahl, Danny Jazmati, Tom Luedde, Edwin Boelke, Torsten Feldt, Bjoern Erik Ole Jensen, Johannes Bode, Verena Keitel, Jan Haussmann, Balint Tamaskovics, Wilfried Budach, Johannes C. Fischer, Wolfram Trudo Knoefel, Marion Schneider, Peter Arne Gerber, Alessia Pedoto, Dieter Haeussinger, Martijn van Griensven, Amir Rezazadeh, Yechan Flaig, Julian Kirchner, Gerald Antoch, Hubert Schelzig, Christiane Matuschek

Summary: This study presents a case series of eight patients who developed cardiac symptoms shortly after receiving SARS-CoV-2 mRNA vaccines. Three patients required hospitalization, but all patients fully recovered within seven days. The results suggest that cardiac adverse events such as myocarditis or pericarditis after mRNA vaccination are rare but possible.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)

No Data Available